| Female unilateral | Female multiple primary | Male breast cancer | Ovarian cancer | ||||
---|---|---|---|---|---|---|---|---|
Number of probands: | 126 | 24 | 12 | 13* | ||||
Age at Diagnosis | (N) | (%) | (N) | (%) | (N) | (%) | (N) | (%) |
20-29 | 7 | 5.6 | 0 | 0 | 0 | 0 | 1 | 7.7 |
30-39 | 26 | 20.6 | 5 | 20.8 | 0 | 0 | 1 | 7.7 |
40-49 | 44 | 34.9 | 13 | 54.2 | 3 | 25.0 | 5 | 38.5 |
50-59 | 30 | 23.8 | 6 | 25.0 | 2 | 16.7 | 0 | 0 |
60-69 | 16 | 12.7 | 0 | 0 | 3 | 25.0 | 5 | 38.5 |
70 and over | 3 | 2.3 | 0 | 0 | 4 | 33.3 | 1 | 7.7 |
Mean (years) | 47.1 | 43.4 | 60.8 | 51.3 | ||||
Range (years) | 23-78 | 31-58 | 43-76 | 23-76 | ||||
Mean time from diagnosis (years) | 4.7 | 12.4 | 1.8 | 10.3 | ||||
Ethnicity** | (N) | (%) | (N) | (%) | (N) | (%) | (N) | (%) |
British Isles | 47 | 37.3 | 8 | 33.3 | 6 | 50.0 | 5 | 38.5 |
French Canadian | 27 | 21.4 | 5 | 20.8 | 1 | 8.3 | 5 | 38.5 |
Other European | 19 | 15.1 | 7 | 29.2 | 2 | 16.6 | 2 | 15 |
Ashkenazi Jewish | 8 | 6.3 | 1 | 4.2 | 0 | 0 | 0 | 0 |
Asian | 4 | 3.2 | 0 | 0 | 1 | 8.3 | 0 | 0 |
Mixed Ethnicity | 16 | 12.7 | 3 | 12.5 | 1 | 8.3 | 0 | 0 |
Other or unknown | 5 | 4.0 | 0 | 0 | 1 | 8.3 | 1 | 7.7 |